Prostaglandin E₂ suppresses human group 2 innate lymphoid cell function.

Area of Science:

• Immunology
• Allergy Research
• Inflammation Biology

Background:

• Group 2 innate lymphoid cells (ILC2s) are key players in type 2 inflammation and allergic responses.
• Prostaglandin E2 (PGE2) is a lipid mediator with known protective roles in lung allergic inflammation.

Purpose of the Study:

• To investigate the regulatory effects of PGE2 on human ILC2 function.
• To understand the molecular mechanisms underlying PGE2's impact on ILC2s.

Main Methods:

• Flow cytometry was used to assess ILC2 proliferation and intracellular cytokine/transcription factor expression.
• ELISA and real-time quantitative PCR were employed to measure cytokine production and PGE2 receptor expression.

Main Results:

• PGE2 inhibited GATA-3 expression and the production of IL-5 and IL-13 by human ILC2s.
• PGE2 downregulated CD25 expression and decreased ILC2 proliferation.
• These effects were mediated by E-type prostanoid (EP) 2 and EP4 receptors expressed on ILC2s.

Conclusions:

• PGE2 activation limits ILC2 activation, suggesting a suppressive role in allergic inflammation.
• Selective EP2 and EP4 receptor agonists represent a potential therapeutic strategy for allergic diseases by targeting ILC2 function.